Oruka Therapeutics, Inc.

ORKA · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $3.7B · 68 employees
400
SEC Filings
$98.42
Close 2026-08-06
68
Employees

Business Summary

Oruka Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis and other inflammatory and immunology indications. Its lead program, ORKA-001, targets IL-23p19 with extended half-life YTE technology for infrequent dosing, and its co-lead program, ORKA-002, targets IL-17A/F for psoriasis, hidradenitis suppurativa, psoriatic arthritis, and other conditions. The company was formed through the merger of ARCA biopharma and Pre-Merger Oruka Therapeutics in August 2024.

Latest Stock Quote

ORKA 2026-08-06 $98.42 O:$96.74 H:$99.51 L:$96.36 Vol:0.7M VWAP:$98.1677
origin leaf: null

Next Earnings

Q2 FY2026 — expected 2026-09-17

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-122025-12-310001213900-26-026929EDGAR88K words
2025-03-062024-12-310001213900-25-021165EDGAR—
2024-02-012023-12-310000950170-24-009809EDGAR—
2023-02-242022-12-310000950170-23-004379EDGAR—
2022-03-142021-12-310001564590-22-010075EDGAR—
2021-03-182020-12-310001564590-21-014148EDGAR—
2020-02-182019-12-310001564590-20-005032EDGAR—
2019-02-272018-12-310001564590-19-004882EDGAR—
2018-03-222017-12-310001564590-18-006566EDGAR—
2017-03-212016-12-310001564590-17-004897EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-122025-09-300001213900-25-109182EDGAR53K words
2025-08-112025-06-300001213900-25-074281EDGAR—
2025-05-142025-03-310001213900-25-043279EDGAR—
2024-11-132024-09-300001213900-24-097443EDGAR—
2024-08-012024-06-300000950170-24-089246EDGAR—
2024-04-252024-03-310000950170-24-048329EDGAR—
2023-10-182023-09-300000950170-23-053972EDGAR—
2023-07-212023-06-300000950170-23-033834EDGAR—
2023-04-242023-03-310000950170-23-014091EDGAR—
2022-10-282022-09-300001564590-22-035668EDGAR—
2022-08-022022-06-300001564590-22-027468EDGAR—
2022-05-022022-03-310001564590-22-017043EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-08-100001213900-26-086933EDGAR—
2025-12-110001213900-25-120676EDGAR1K words
2025-09-220001213900-25-090129EDGAR—
2025-07-010001213900-25-060352EDGAR—
2025-06-030001213900-25-050756EDGAR—
2025-02-050001213900-25-010525EDGAR—
2024-12-190001213900-24-110303EDGAR—
2024-11-180001213900-24-099645EDGAR—
2024-11-140001213900-24-098530EDGAR—
2024-10-040001213900-24-085543EDGAR—

400 total filings indexed. 368 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

psoriasis hidradenitis-suppurativa psoriatic-arthritis inflammatory-and-immunology axial-spondyloarthritis yte-half-life-extension-technology fragment-crystallizable-(fc)-domain-modification neonatal-fc-receptor-(fcrn)-ph-dependent-binding

Company Identity

CIK0000907654
TickerORKA
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.orukatx.com
Listed2024-09-03

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 6fb7eb476df9651557dff3c3657cc1f09faa8db18091be19a9c39963efde9075
parent: 6d96ee1e5756708283ceeded8d43aeea310e58eddb5c8c488d977dc89028fb25
content hash: 40fc8628fe89cbc0ffcb831f5e2542d6b9811e810d2c20efe9cb7297162e547d
signed: 2026-08-10T19:04:49.222Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up ORKA using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on ORKA, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/ORKA (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.